Maki Hagihara

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta et al. · Blood Advances · 2020 · 117 citations · Full text

Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies

Takayoshi Tachibana, Masatsugu Tanaka, Hirotaka Takasaki et al. · International Journal of Hematology · 2011 · 44 citations

Transplantation, Blood Transfusion, Myeloid Malignancies +10

Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients

Fusako Waki, Kazuhiro Masuoka, Takahiro Fukuda et al. · Biology of Blood and Marrow Transplantation · 2010 · 40 citations · Full text

Transplantation Medicine, Surgery, Hematology +16

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Eri Yamamoto, Shin Fujisawa, Maki Hagihara et al. · Cancer Science · 2013 · 39 citations · Full text

Imatinib Treatment Response, Hematological Malignancy, Chronic Myeloid Leukemia +14

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study

Akihiro Takeshita, Norio Asou, Yoshiko Atsuta et al. · Leukemia · 2018 · 38 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +9